secwatch / observer
8-K filed April 17, 2024, 7:59 PM ET ticker MRAI CIK 0001844392
debt confidence high sentiment neutral materiality 0.70

Marpai, Inc. (MRAI): debt financing — Marpai issues $11.83M convertible debentures; net proceeds $11M; conversion $3.00/share

Marpai, Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Marpai, Inc. incurred convertible notes of $11,830,000 with JGB Collateral LLC, as collateral agent at prime interest rate plus 5.75% per annum maturing April 15, 2027.

Instrument
convertible notes
Principal
$11,830,000
Counterparty
JGB Collateral LLC, as collateral agent
Rate
prime interest rate plus 5.75% per annum
Maturity
April 15, 2027
Event
incurrence
Exact text from the filing
the Company agreed to sell to the Purchasers Senior Secured Convertible Debentures (the “Debentures”) in an aggregate principal amount of $11,830,000
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Marpai, Inc. entered into Securities Purchase Agreement with the Purchasers valued at $11,830,000 (effective 2024-04-15).

Action
entry
Agreement
notes offering
Counterparty
the Purchasers
Value
$11,830,000
Effective
2024-04-15
Exact text from the filing
On April 15, 2024, Marpai, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers that are parties thereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”) and JGB Collateral LLC, a Delaware limited liability company, as collateral agent for the Purchasers (the “Agent”).
View on SEC.gov

310 debt financings filed in the last 30 days. Browse all debt financings →

Marpai, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-24-045089
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.